Celon Pharma S.A.
WSE:CLN
16.84
zł0.00 (0.00%)
16.84
zł0.00 (0.00%)
End-of-day quote: 05/18/2024

Celon Pharma financials at a glance

The revenue of Celon Pharma is reported as 0.19459 billion Zlotych in the fiscal year 2023. The earnings were -0.77 Zlotych per share in 2023, which was 0 higher than 2022. And about -0.03751 billion Zlotych are reported as free cash flow in the financials of Celon Pharma 2023. Dividends of 0.29 Zlotych per share were paid to shareholders of Celon Pharma stock WSE:CLN in fiscal 2023.

zł194.59M
Revenue
zł-0.77
Earnings Per Share
69.15%
Gross Margin %
zł34.00M
Free Cash Flow
Revenue
194.59
Earnings Per Share
-0.77
Gross Margin %
69.15
Free Cash Flow
34.00

Financials

Year Year TTM 2023 2022 2021 2020 2019 2018 2017
Rev. Revenue N/A zł194.59M zł194.59M zł199.11M zł139.27M zł102.25M zł125.25M zł107.12M
GM % Gross Margin % 67.79% 69.15% 65.72% 68.53% 61.17% 77.16% 77.50% 77.16%
OM Operating Margin -11.50% -12.58% -19.55% -5.40% 26.79% 6.08% 28.21% 24.29%
EPS Earnings Per Share zł0.00 zł-0.77 zł-0.77 zł-0.25 zł0.48 zł0.27 zł0.66 zł0.57
Div. Dividends N/A zł0.29 zł0.29 zł0.00 zł0.07 zł0.08 zł0.17 zł0.17
PR % Payout Ratio % 0 -37.66% -37.66% -0.00% 14.58% 29.63% 25.76% 29.82%
Sha. Shares N/AM 51.37M 51.04M 51M 45M 45M 45M 45M
OCF Operating Cash Flow N/A zł-4.70M zł-4.70M zł43.95M zł70.90M zł-5.05M zł28.24M zł0.00M
FCF Free Cash Flow N/A zł34.00M zł29.21M zł2.60M zł-28.26M zł-70.00M zł-39.22M zł0.00M
FCFS Free Cash Flow Per Share zł0.00 zł-0.80 zł-0.76 zł0.06 zł-0.63 zł-1.56 zł-0.87 zł-0.13